No abstract available
MeSH terms
-
Aged
-
Aged, 80 and over
-
Antibodies, Monoclonal, Humanized / therapeutic use*
-
Betacoronavirus / immunology
-
Betacoronavirus / pathogenicity*
-
Biomarkers / blood
-
C-Reactive Protein / metabolism
-
COVID-19
-
Cause of Death
-
China / epidemiology
-
Comorbidity
-
Coronavirus Infections / drug therapy
-
Coronavirus Infections / immunology
-
Coronavirus Infections / mortality
-
Coronavirus Infections / physiopathology*
-
Critical Care
-
Cytokine Release Syndrome / mortality
-
Cytokine Release Syndrome / physiopathology*
-
Cytokine Release Syndrome / virology
-
Female
-
Fibrin Fibrinogen Degradation Products / metabolism
-
Humans
-
Interleukin-6 / blood
-
Male
-
Middle Aged
-
Multiple Organ Failure / mortality
-
Multiple Organ Failure / physiopathology*
-
Multiple Organ Failure / virology
-
Pandemics
-
Pneumonia, Viral / drug therapy
-
Pneumonia, Viral / immunology
-
Pneumonia, Viral / mortality
-
Pneumonia, Viral / physiopathology*
-
Retrospective Studies
-
SARS-CoV-2
-
Sex Factors
Substances
-
Antibodies, Monoclonal, Humanized
-
Biomarkers
-
Fibrin Fibrinogen Degradation Products
-
Interleukin-6
-
fibrin fragment D
-
C-Reactive Protein
-
tocilizumab